Patents by Inventor Yo Tabuse

Yo Tabuse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120225440
    Abstract: A method of detecting hepatocellular carcinoma includes using an isolated protein including an amino acid sequence represented by SEQ ID NO: 1.
    Type: Application
    Filed: May 15, 2012
    Publication date: September 6, 2012
    Applicant: NEC Corporation
    Inventors: Hirotaka Minagawa, Kenji Miyazaki, Yo Tabuse, Kenichi Kamijo, Shuichi Kaneko
  • Patent number: 8207301
    Abstract: Provided are: a method of assessing hepatocellular carcinoma by using a protein with a different phosphorylated state in hepatocellular carcinoma cells compared with non-hepatocellular carcinoma cells; and a hepatocellular carcinoma protein marker for detecting hepatocellular carcinoma formed of the protein. The hepatocellular carcinoma protein marker for detecting hepatocellular carcinoma includes tumor rejection antigen gp96 formed of the amino acid represented by SEQ ID NO: 1, and is measured for its phosphorylated state to detect the presence or absence of hepatocellular carcinoma.
    Type: Grant
    Filed: June 16, 2008
    Date of Patent: June 26, 2012
    Assignee: NEC Corporation
    Inventors: Hirotaka Minagawa, Kenji Miyazaki, Yo Tabuse, Kenichi Kamijo, Shuichi Kaneko
  • Publication number: 20110053196
    Abstract: The present invention is to provide a method for easily and specifically modifying specific amino acid residue(s) constituting a peptide and to provide a methodology of improving the accuracy of identification of the peptide using a new information of the peptide obtained from the number of modified amino acid residue by said specific modification method as mentioned. The method for modifying a peptide according to the present invention is characterized: A method for modifying a peptide, wherein the peptide as supported in a substrate and an aqueous solution of perhalogenated carboxylic acid containing an alcohol is reacted to selectively esterify a glutamic acid residue of said peptide.
    Type: Application
    Filed: February 8, 2007
    Publication date: March 3, 2011
    Applicant: NEC CORPORATION
    Inventors: Kenji Miyazaki, Yo Tabuse, Hirotaka Minagawa, Emiko Saito, Ken'ichi Kamijo, Akira Tsugita, Kozue Tsugita
  • Publication number: 20100248256
    Abstract: Provided are: a method of assessing hepatocellular carcinoma by using a protein with a different phosphorylated state in hepatocellular carcinoma cells compared with non-hepatocellular carcinoma cells; and a hepatocellular carcinoma protein marker for detecting hepatocellular carcinoma formed of the protein. The hepatocellular carcinoma protein marker for detecting hepatocellular carcinoma includes tumor rejection antigen gp96 formed of the amino acid represented by SEQ ID NO: 1, and is measured for its phosphorylated state to detect the presence or absence of hepatocellular carcinoma.
    Type: Application
    Filed: June 16, 2008
    Publication date: September 30, 2010
    Inventors: Hirotaka Minagawa, Kenji Miyazaki, Yo Tabuse, Kenichi Kamijo, Shuichi Kaneko
  • Publication number: 20100035291
    Abstract: A fragmenting reaction of peptide is achieved while maintaining the isolated state of peptide. Isolated peptide fractions isolated by electrophoresis are prepared in flow paths. Subsequently, prepared peptide fractions are dried by each of the flow paths. Then, dried peptide fractions are in contact with protease. Then, independent liquid membranes of a solvent are formed over the surfaces of peptide fractions, which have been in contact with protease, disposed on the flow paths, respectively.
    Type: Application
    Filed: July 22, 2009
    Publication date: February 11, 2010
    Applicant: NEC Corporation
    Inventors: Kenji MIYAZAKI, Yo Tabuse, Hiroko Someya, Wataru Hattori, Hisao Kawaura
  • Publication number: 20070026456
    Abstract: A biomolecule is analyzed with high accuracy. A biomolecule is analyzed with high likelihood. A biomolecule as an analysis subject is modified with a marker binding or adsorbing to only its specific portion (S101). Next, the biomolecule modified with the marker is developed on a base plate (S102). The arrangement of the biomolecule on the base plate is detected using a marker (S103). Then, scanning is performed along the shape of the biomolecule present on the detected position (S104). The biomolecule is analyzed based on an information relating to the shape or arrangement of the biomolecule obtained by scanning or an information relating to the arrangement of the marker on the biomolecule (S105).
    Type: Application
    Filed: September 2, 2004
    Publication date: February 1, 2007
    Applicant: NEC CORPORATION
    Inventors: Kenichi Kamijo, Hisao Kawaura, Toru Sano, Yo Tabuse, Hirotaka Minagawa, Kenji Miyazaki